تقرير
أعرض في EDS

Challenging the believed proportion of ovarian cancer attributable to BRCA2 versus BRCA1 pathogenic variants.

التفاصيل البيبلوغرافية
العنوان: Challenging the believed proportion of ovarian cancer attributable to BRCA2 versus BRCA1 pathogenic variants.
المؤلفون: Flaum N; Division of Evolution and Genomic Sciences, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, Manchester, M13 9PL, UK; Manchester Centre for Genomic Medicine and NW Laboratory Genetics Hub, Manchester University Hospitals NHS Foundation Trust, Manchester, M13 9WL, UK. Electronic address: Nicola.flaum@manchester.ac.uk., Crosbie EJ; Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, Manchester, M13 9PL, UK; St Mary's Hospital, Manchester University NHS Foundation Trust, Manchester, M13 9WL, UK. Electronic address: Emma.crosbie@manchester.ac.uk., Woodward ER; Division of Evolution and Genomic Sciences, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, Manchester, M13 9PL, UK; Manchester Centre for Genomic Medicine and NW Laboratory Genetics Hub, Manchester University Hospitals NHS Foundation Trust, Manchester, M13 9WL, UK. Electronic address: Emma.woodward@mft.nhs.uk., Lalloo F; Division of Evolution and Genomic Sciences, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, Manchester, M13 9PL, UK; Manchester Centre for Genomic Medicine and NW Laboratory Genetics Hub, Manchester University Hospitals NHS Foundation Trust, Manchester, M13 9WL, UK. Electronic address: Fiona.lalloo@mft.nhs.uk., Gareth Evans D; Division of Evolution and Genomic Sciences, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, Manchester, M13 9PL, UK; Manchester Centre for Genomic Medicine and NW Laboratory Genetics Hub, Manchester University Hospitals NHS Foundation Trust, Manchester, M13 9WL, UK; Prevention Breast Cancer Centre and Nightingale Breast Screening Centre, University Hospital of South Manchester, Manchester, M23 9LT, UK; The Christie NHS Foundation Trust, Manchester, M20 4BX, UK; Manchester Breast Centre, Manchester Cancer Research Centre, University of Manchester, Manchester, M20 4BX, UK. Electronic address: Gareth.evans@mft.nhs.uk.
المصدر: European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2020 Jan; Vol. 124, pp. 88-90. Date of Electronic Publication: 2019 Nov 21.
نوع المنشور: Letter; Research Support, Non-U.S. Gov't
اللغة: English
بيانات الدورية: Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9005373 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0852 (Electronic) Linking ISSN: 09598049 NLM ISO Abbreviation: Eur J Cancer Subsets: MEDLINE
أسماء مطبوعة: Publication: Oxford : Elsevier Science Ltd
Original Publication: Oxford ; New York : Pergamon Press, c1990-
مواضيع طبية MeSH: BRCA1 Protein/*genetics , BRCA2 Protein/*genetics , Ovarian Neoplasms/*genetics, Adult ; Female ; Humans ; Middle Aged ; Ovarian Neoplasms/pathology
معلومات مُعتمدة: United Kingdom CRUK_ Cancer Research UK
المشرفين على المادة: 0 (BRCA1 Protein)
0 (BRCA1 protein, human)
0 (BRCA2 Protein)
0 (BRCA2 protein, human)
تواريخ الأحداث: Date Created: 20191125 Date Completed: 20200730 Latest Revision: 20200730
رمز التحديث: 20231215
DOI: 10.1016/j.ejca.2019.10.018
PMID: 31760313
قاعدة البيانات: MEDLINE
الوصف
تدمد:1879-0852
DOI:10.1016/j.ejca.2019.10.018